Because antidepressant augmentations that impinge upon 5-HT1A receptors have been shown to be an effective form of treatment for depression, polymorphisms within this region have become a topic of interest during the past decade (Suzuki et al., 2004; Drago et al., 2008). The gene discussed is HTR1A; the disease is major depressive disorder.